Albert Wood
Hematology & Oncology · New Braunfels, TXNPI 1962406462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $719 and has fallen 96.1% since, to $28 in 2024. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.
Across 58 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$148
- Merck$139
- Johnson & Johnson$93
- Novartis$80
- Amgen$71
- Ipsen Biopharmaceuticals, Inc$60
- plus $421 from 16 others
What the payments were for
- Food & beverage$1,011100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $148 |
| Merck | 8 | $139 |
| Johnson & Johnson | 4 | $93 |
| Novartis | 6 | $80 |
| Amgen | 5 | $71 |
| Ipsen Biopharmaceuticals, Inc | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 4 | $58 |
| Incyte Corporation | 3 | $47 |
| Puma Biotechnology, Inc. | 3 | $44 |
| Eisai Inc. | 2 | $39 |
| Bayer | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Clovis Oncology, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Tesaro, Inc. | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Pfizer | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Sanofi | 1 | $13 |
| Mylan Institutional Inc. | 1 | $11 |
| Coherus Oncology, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$101
How this compares
$1,011 in reported general payments places this provider in the 30th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in New Braunfels
- Devesh PandyaHouston$1.8M
- Elias JabbourHouston$1.3M
- Asad DeanFort Worth$1.1M
- Habte YimerTyler$934K
- Edward PearsonDallas$900K
- Naval DaverHouston$853K
- Christopher MaiselDallas$713K
- Clifton LaymanEl Paso$645K
- Jorge Cortes-FrancoHouston$627K
- Timothy FenskeSan Antonio$626K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.